Synthesis and SAR of pyridazinone-substituted phenylalanine amide alpha4 integrin antagonists.

Bioorg Med Chem Lett

Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Welsh & McKean Roads, PO Box 776, Spring House, PA 19477-0776, USA.

Published: February 2008

Structural modification and cellular adhesion inhibition activities of pyridazinone-substituted phenylalanine amide alpha(4) integrin antagonists are described. Functionality requirements for the arylamide moiety and the carboxylic acid group were demonstrated. The study also revealed novel structure-activity relationships (SAR) for arylated pyridazinones. A correlation between bioavailability and permeability was also explored. A selected compound showed effectiveness in a mouse leukocytosis study.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2008.01.022DOI Listing

Publication Analysis

Top Keywords

pyridazinone-substituted phenylalanine
8
phenylalanine amide
8
amide alpha4
8
alpha4 integrin
8
integrin antagonists
8
synthesis sar
4
sar pyridazinone-substituted
4
antagonists structural
4
structural modification
4
modification cellular
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!